Affiliations 

  • 1 Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
  • 2 Department of Human Neurophysiology, Faculty of Medicine, Fukushima Medical University, Fukushima, Japan
  • 3 Neurology Unit, King Fahad Military Medical Complex, Dhahran, Saudi Arabia
  • 4 Neurology Unit, Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
  • 5 Department of Neurology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
  • 6 Yoshiko Nomura Neurological Clinic for Children, Tokyo, Japan
  • 7 Institute of Medical Genomics, International University of Health and Welfare, Narita, Chiba, Japan
  • 8 Section of Neurology, Department of Neuroscience, Makati Medical Center, NCR, Makati City, Philippines
  • 9 Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan
  • 10 Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan
  • 11 Department of Neurosciences, King Faisal Specialist Hospital & Research Center, Riyad, Saudi Arabia
  • 12 Mid Yorkshire Hospitals National Health Services Trust, Wakefield, UK
  • 13 Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 14 Department of Neurology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center & Seoul National University Medical College, Seoul, Korea
  • 15 Department of Neurology, Seoul National University, Seoul, Korea
  • 16 Department of Neurology, National Institute of Mental Health & Neurosciences (NIMHANS), Bengaluru, Karnataka, India
  • 17 Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
  • 18 Department of Neurology, Fukuoka University, Faculty of Medicine, Fukuoka, Japan
  • 19 Center for Parkinson's Disease and Movement Disorders, Manipal Hospital, Bangalore, India
  • 20 Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan
  • 21 I. K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
J Mov Disord, 2023 Sep;16(3):231-247.
PMID: 37309109 DOI: 10.14802/jmd.23065

Abstract

Clinical case studies and reporting are important to the discovery of new disorders and the advancement of medical sciences. Both clinicians and basic scientists play equally important roles leading to treatment discoveries for both cures and symptoms. In the field of movement disorders, exceptional observation of patients from clinicians is imperative, not just for phenomenology but also for the variable occurrences of these disorders, along with other signs and symptoms, throughout the day and the disease course. The Movement Disorders in Asia Task Force (TF) was formed to help enhance and promote collaboration and research on movement disorders within the region. As a start, the TF has reviewed the original studies of the movement disorders that were preliminarily described in the region. These include nine disorders that were first described in Asia: Segawa disease, PARK-Parkin, X-linked dystonia-parkinsonism, dentatorubral-pallidoluysian atrophy, Woodhouse-Sakati syndrome, benign adult familial myoclonic epilepsy, Kufor-Rakeb disease, tremulous dystonia associated with mutation of the calmodulin-binding transcription activator 2 gene, and paroxysmal kinesigenic dyskinesia. We hope that the information provided will honor the original researchers and help us learn and understand how earlier neurologists and basic scientists together discovered new disorders and made advances in the field, which impact us all to this day.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.